about
Retrospective cytological evaluation of indeterminate thyroid nodules according to the British Thyroid Association 2014 classification and comparison of clinical evaluation and outcomes.Report from the OECI Oncology Days 2014Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages.Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs.BRAF Mutations in an Italian Regional Population: Implications for the Therapy of Thyroid Cancer.Small cell lung cancer transformation and the T790M mutation: A case report of two acquired mechanisms of TKI resistance detected in a tumor rebiopsy and plasma sample of EGFR-mutant lung adenocarcinoma.Central nervous system involvement in mycosis fungoides: relevance of tcr gene testing in cerebrospinal fluid.Heterogeneous expression of the collagen receptor DDR1 in chronic lymphocytic leukaemia and correlation with progression.Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy.Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma.MicroRNA signatures and Foxp3+ cell count correlate with relapse occurrence in follicular lymphoma.Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 studyTag-based next generation sequencing: a feasible and reliable assay for EGFR T790M mutation detection in circulating tumor DNA of non small cell lung cancer patientsPapillary thyroid cancer in a struma ovarii: a report of a rare caseMYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathwaysCase report: lenvatinib in neoadjuvant setting in a patient affected by invasive poorly differentiated thyroid carcinomaAn H-TERT Mutated Skin Metastasis as First Occurrence in a Case of Follicular Thyroid Carcinoma
P50
Q33876314-2C9480C8-CC6C-433C-9355-0B16B06171E2Q35002560-38BB196C-B1E4-486B-B346-E11CC63193B1Q35100546-6A56E168-0270-4BFB-84D7-6872936A812EQ35189998-10296516-20C7-4B33-BFE0-E7DF75FF5A50Q36360429-43A2DE8A-90E4-42C7-ADE2-E8414C70061BQ37407280-02310850-8B83-4820-A87E-30AC42312FECQ37515752-0B328A71-A165-434B-843C-BD754679975DQ37634745-2A752653-E92C-4913-8ED8-ECD0C74040EFQ37706993-C41A0E3B-B7BA-4749-B8C4-58A060C3DA7AQ39039713-B9E9BA3A-84A5-430F-92FC-951F98C6519BQ41881966-29C8F6AD-E5F2-40B4-9469-66FF551944E4Q55021517-21D1EF39-73CF-491B-B5A7-5E0E75FA3994Q58576988-8C5902E7-E52D-44F9-B4D0-637C330B518DQ64083967-81D7884C-80DE-40BC-A631-B2D71519CEE4Q85992826-E1ECD48F-87D7-420A-B8EB-734BB6601083Q90430667-4837C680-C023-4DB3-90E9-A8F567ACF97FQ92443159-2EBE69F1-A4BB-4C73-9C96-163874BF18A8Q92650120-3F076DA9-CD07-4E99-9444-962FAB2D6510
P50
description
investigador
@es
researcher
@en
name
Simonetta Zupo
@en
type
label
Simonetta Zupo
@en
prefLabel
Simonetta Zupo
@en
P31
P496
0000-0001-6837-5763